Articles tagged with Antibiotics
A study found that doxycycline post-exposure prophylaxis (doxy-PEP) did not significantly alter the overall composition of gut bacteria in individuals who took it for six months. However, the researchers noted signs of resistance building against tetracycline, a class of antibiotics to which doxycycline belongs.
A new study has discovered a novel semi-synthetic compound derived from natural compounds that exhibits potent activity against Mycobacterium tuberculosis, including multi-drug resistant strains. The compound, BPD-9, provides a promising chemical scaffold for developing new anti-tuberculosis drugs.
Researchers at Texas Biomedical Institute have developed a TB therapy that does not interfere with combined antiretroviral therapy (cART) in patients with HIV. The host-directed therapy blocks an immune system protein and has shown improved control of TB when used with antibiotics.
In this study, researchers from Tokyo Institute of Technology found that hydrogen sulfide-dependent transcription factor YgaV regulates iron uptake dynamics in Escherichia coli. The team observed elevated intracellular H2S levels resulting in increased antibiotic resistance and upregulated genes involved in sulfur metabolism.
The European capacity for antibiotic research and development requires sustained investment to combat growing resistance. Collaboration and risk-sharing can help keep companies in anti-infective drug development, as a temporary funding strategy may lead to lost efforts.
Researchers argue that placental pathology is underutilized clinically and deserves routine obstetric and neonatal care, as well as more research attention.
A new study estimates that more than 1 million people died each year due to antibiotic-resistant infections between 1990 and 2021. The study predicts that this number could increase to nearly 2 million by 2050, with a significant age-related shift in the impact of AMR on children under five years old.
Research from Edith Cowan University highlights the need for accurate testing to prevent antibiotic allergies in children. Most suspected antibiotic allergies are inaccurate, with symptoms often caused by underlying illness. Testing once the child is well enough can help identify true allergies and ensure timely treatment.
Repeated antibiotic use can cause defects in the gut's protective mucus barrier, even months after treatment. This is due to changes in the microbiota or direct effects of antibiotics on the mucus layer. The findings suggest that antibiotics should be used responsibly to prevent long-lasting damage.
Researchers have discovered a new class of natural antimicrobials called microcins that can target specific strains of bacteria causing cholera, inflammatory bowel disease, and colon cancer. Microcins are highly selective and can potentially remove unwanted bacteria without disrupting the human gut microbiome.
A study by Virginia Tech undergraduate Megan O'Hara found that surface properties significantly influence bacterial twitching motility, allowing for rapid colonization and infection. By manipulating surface properties with detergents like bile salts, researchers can alter the functionality of type IV pili, a critical virulence factor.
A study found that medical clowns can reduce hospital stays by an average of 43.5 hours and decrease IV antibiotic use for children with pneumonia. The clowns' visits also led to lower respiratory rates, heart rates, and inflammatory markers.
Researchers at Gladstone Institutes have developed a streamlined way to engineer bacteriophages, viruses that naturally kill bacteria. The new technique uses retrons to edit phage genomes, allowing for the creation of numerous variants and paving the way for alternative treatments for antibiotic-resistant infections.
A new narrow-spectrum antibiotic, FP 100, has been found to effectively eliminate Fusobacterium nucleatum without harming the oral or gut microbiomes. This breakthrough discovery holds significant implications for treating severe gum disease and preventing related systemic conditions such as colon cancer and Alzheimer's disease.
The new guideline updates treatment recommendations for Helicobacter pylori infection, shifting away from proton pump inhibitor-clarithromycin triple therapy. Bismuth quadruple therapy and other alternatives are now recommended for treatment-naïve patients.
Researchers have identified two compounds with strong antivirulence activity from actinobacteria in the Arctic Sea, targeting EPEC bacteria that cause severe diarrhea. The compounds inhibit virulence factor formation and binding to host cells, reducing disease severity and potential for resistance.
Researchers found that Chlamydia bacteria can persist in the intestines of humans, where they form a permanent reservoir and evade antibiotic treatment. The bacteria preferentially infect the inner cell layer of intestinal organoids, but not the outer epithelial layer.
Researchers at the University of Virginia School of Engineering and Applied Science have designed a drug-carrying molecule that can slip past the lung's natural defenses. The nanocarrier, called PEG-BB, is shaped like a bottlebrush and mimics the properties of mucus, allowing it to move quickly through the airway.
Researchers have identified dozens of potential new antibiotics in the human gut microbiome, with one candidate showing promise against multidrug-resistant infections. The discovery uses artificial intelligence to analyze vast amounts of biological data and mine the world's biological information as a source of antibiotics.
Researchers have discovered that oleic acid, a naturally occurring oil in the body, restores a healthy balance of vaginal microbes in a laboratory model of BV. Oleic acid inhibits growth of detrimental bacteria and promotes healthier species associated with a stable microbiome.
Using Explainable AI (XAI), researchers analyzed AI model predictions for antibiotic candidates, identifying critical molecular structures and variables. This helped improve predictive models, which can now be trained on what's truly important for activity.
Scientists studying environmental bacteria have determined a protein's essential role in maintaining the germ's shape. Loss of the protein OpgH disrupts the bubble-like cell envelope, resulting in the cell's death. This finding could lead to new drug targets and advance the search for better antibiotics.
Researchers at The University of Warwick created a realistic model of ventilator-associated pneumonia (VAP) to better understand the infection. The study found that combining antibiotics with enzymes that break down biofilm slime layers could successfully eradicate the bacteria, offering new hope for treatments.
A recent study found that C-section antibiotics have a subtle impact on the infant gut microbiome, whereas diet has a significant impact. The study analyzed data from 172 infant samples and found that feeding mode explained 12% of variation in overall infant gut microbiome composition.
MIT chemists have developed a new way to synthesize complex oligocyclotryptamines found in plants, which could hold potential as antibiotics, analgesics, or cancer drugs. The approach allows for precise assembly of the rings and control of the 3D orientation of each component.
Commonly prescribed oral antibiotics increase risk of serious cutaneous adverse drug reactions compared to macrolides. Sulfonamides and cephalosporins carry the highest risk, prompting prescribers to opt for lower-risk alternatives when clinically appropriate.
Two classes of commonly prescribed oral antibiotics are associated with the greatest risk for severe drug rashes that can lead to emergency department visits, hospitalizations, and even death. Researchers suggest using lower-risk antibiotics when clinically appropriate.
A new study from the University of Surrey found that higher faecal bacterial diversity at one month old is positively associated with the athletic performance of Thoroughbred foals. Lower bacterial diversity in early life also increases the risk of respiratory disease and soft-tissue issues.
Researchers at WashU Medicine have developed a novel compound that effectively clears bacterial infections in mice, including those causing rare and potentially fatal 'flesh-eating' illnesses. The compound targets gram-positive bacteria, reducing virulence and speeding up post-infection healing.
A new study found that heteroresistance, a phenomenon where a tiny fraction of bacteria remain resistant to antibiotics, is also present in fungal bloodstream infections in bone marrow transplant patients. The research identified the specific species of fungi responsible and developed a machine learning model to detect this type of inf...
Researchers at the University of Texas at Austin have leveraged AI to develop a new, safer antibiotic that targets specific bacterial membranes while minimizing harm to human cells. The AI-powered approach has identified a promising lead compound with potential for treating multidrug-resistant bacterial infections.
Researchers have identified a group of molecules called callyaerins that can act against tuberculosis by targeting a specific membrane protein of the bacterium Mycobacterium tuberculosis. These substances inhibit bacterial growth without affecting human cells, offering a promising new approach to treating the disease.
Researchers at Ben-Gurion University of the Negev have developed a new compound, PL-18, which disrupts bacterial quorum sensing and biofilm formation. This compound has shown promise in reducing bacterial virulence and inhibiting iron uptake, suggesting potential applications in combating antibiotic-resistant bacteria.
Research found higher bacterial concentrations in keloid tissue, especially in deep layers, leading to increased inflammation and fibroblast production. Antibiotics and phage treatments may help reduce bacteria and improve treatment outcomes for keloids.
Researchers at the University of Illinois Chicago have developed a new dual-action antibiotic that targets two different cellular targets, making it nearly impossible for bacteria to evolve resistance. The antibiotic works by disrupting protein production and DNA structure, rendering random mutations ineffective.
Random antimicrobial peptide mixtures significantly reduce the risk of resistance evolution compared to single peptides. These findings support the development of new antimicrobial strategies to tackle growing antibiotic-resistant threats and safeguard public health.
A study by Dr. Takanori Sekito and colleagues reveals a strong association between vaginal pathogenic Escherichia coli and recurrent cystitis in postmenopausal women, suggesting that targeting both the urinary bladder and vagina is crucial for effective treatment.
Researchers found that rotifers acquire genes from bacteria and produce resistance weapons, such as antibiotics and antimicrobial agents. The team's findings suggest that rotifers could give important clues in the hunt for new antibiotics to treat human infections.
Researchers have identified a mechanism in dogs that may render multiple antibiotic classes ineffective due to the loss of function of specific genes. This discovery opens up new avenues for therapies to treat both animals and humans, and establishes clinical infections in dogs as a surveillance approach for public health.
Researchers developed a strategy to identify new antimicrobial drugs with therapeutic promise from bacterial datasets. PHAb10 and PHAb11 showed robust antibacterial activity against various bacterial species, including those resistant to traditional antibiotics.
Research from Monash University found that early exposure to antibiotics can trigger long-term susceptibility to asthma. A molecule called IPA, produced by healthy gut bacteria, has the potential to prevent asthma in children at risk.
Researchers analyzed genomic data and human travel patterns to understand the spread and evolution of Streptococcus pneumoniae. The study found that a pneumococcal vaccine reduced antibiotic resistance but allowed non-targeted strains to gain a competitive advantage, suggesting short-lived protection.
The University of Texas at Arlington's Junha Jeon is developing transition metal-free cross-coupling technologies using arynes to deliver medications safely and effectively. This project aims to improve the production of drugs, particularly for cancer treatment, by reducing impurities left behind by metals.
A new study finds that antimicrobial peptide mixtures can delay the evolution of antibiotic resistance in Pseudomonas aeruginosa. The mixtures, which are synthesized in a lab, were found to prevent cross-resistance and maintain drug sensitivity.
A study at Umeã University reveals that an enzyme breaks down the bacteria's protective outer layer, facilitating the transfer of genes for resistance to antibiotics. The researchers identified that only the SLT domain was active in PrgK, but it has an important role in regulation.
A new study suggests taxing certain antibiotics could help manage the threat of antibiotic resistance in humans. By making narrow-spectrum drugs cheaper and broad-spectrum ones more expensive, GPs may be incentivized to prescribe narrower options.
Chimpanzees have been observed seeking out specific plants with medicinal properties to treat their ailments, and further pharmacological testing has confirmed the presence of anti-inflammatory and antibiotic compounds. These findings highlight the importance of studying animal behavior in discovering new medicines.
Researchers have identified a potent and unique way to kill drug-resistant bacteria using a repurposed compound called LEI-800. The compound targets the bacterial enzyme DNA gyrase, which is essential for bacterial growth and has not been targeted by existing antibiotics.
When E. coli detects damage from antibiotic Ciprofloxacin, it sends out an SOS signal that alters cellular activity. The bacteria then mutate their DNA to repair the damage or adapt to resist the antibiotic. Researchers studied this process in detail using bioreactors and found all genes are activated simultaneously at the protein level.
The BLING III trial found a 2% lower 90-day mortality and a 6% higher clinical cure rate for continuous β-lactam antibiotic infusions compared to intermittent infusions in critically ill patients with sepsis. Continuous infusions were also associated with improved patient outcomes.
Prolonged β-lactam antibiotic infusions associated with reduced 90-day mortality in adults with sepsis or septic shock. This standard of care approach is now supported by high certainty evidence.
A team of researchers at Penn has developed an artificial intelligence tool that can mine the vast and largely unexplored biological data from over 10 million molecules to discover new candidates for antibiotics. The deep learning approach identified thousands of candidates in just a few hours, with many showing preclinical potential.
A team of researchers has created a water-soluble version of the bacterial enzyme histidine kinase, which could be used in high-throughput screens to rapidly test potential drugs that target this enzyme. The new protein retains its natural functions despite being converted from a hydrophobic protein.
A novel antibacterial lipopeptide produced by Serratia marcescens has been shown to be highly effective in killing Staphylococcus aureus. The lipopeptide targets the cell membrane, causing lesions and cell death.
Researchers found no difference in post-operative infection rates between patients treated with and without antibiotics prior to surgery. The study suggests that pre-surgical antibiotic treatment may not be necessary for pediatric elbow fractures.
A global research team identified 863,498 promising antimicrobial peptides in marine and soil environments, as well as human and animal guts, to combat antimicrobial resistance. The findings come with a renewed focus on combatting the growing number of superbugs resistant to current drugs.
A new study uses machine learning to search for antibiotics in a vast dataset of microbial genomes, identifying 863,498 candidate antimicrobial peptides. Promising results are observed in initial tests against disease-causing bacteria and preclinical animal models.
Researchers at UC Davis Health discovered that mesalamine can replace good bacteria's work in fighting Candida albicans in the gut. The study found that mesalamine maintains a low oxygen environment that prevents fungal growth, reducing the risk of invasive candidiasis.
A six-state hospital system reported significant decreases in surgical site infections, mortality, length of stay, and readmissions after implementing a comprehensive SSI prevention bundle. Orthopedic patients showed the most benefit, with a 32.8% reduction in SSI rates.
A novel triple combination of meropenem, avibactam, and a metallo-β-lactamase inhibitor demonstrates significantly broader spectrum of antimicrobial activity against diverse β-lactamase-producing bacteria. The study offers a new strategy to combat global health crisis of antibiotic resistance.